Psychometric Validation of the Hepatitis C Symptom and Impact Questionnaire (HCV-SIQv4) in a Diverse Sample of Adults with Chronic Hepatitis C Virus Infection Treated with an Interferon-free Simeprevir-containing Regimen
**Background:** Hepatitis C virus (HCV) infection and its treatments are associated with significant symptoms, side effects and impact on patients functioning. The Hepatitis C Symptom and Impact Questionnaire version 4 (HCV-SIQv4) was developed according to FDA Patient Reported Outcomes (PRO) Guidan...
Main Authors: | Andrew Trigg, Eric Chan, Helen Kitchen, Tom Willgoss, Kai Fai Ho, Renee Pierson, Jane Scott |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | http://jheor.scholasticahq.com/article/9675-psychometric-validation-of-the-hepatitis-c-symptom-and-impact-questionnaire-hcv-siqv4-in-a-diverse-sample-of-adults-with-chronic-hepatitis-c-virus-infection-treated-with-an-interferon-free-simeprevir-containing-regimen.pdf |
Similar Items
-
Simeprevir for the treatment of hepatitis C virus infection
by: Izquierdo L, et al.
Published: (2014-08-01) -
Interferon-based Simeprevir Therapy for Pediatric Patients with Chronic Hepatitis C Viral Infection
by: Mitsuyoshi Suzuki, et al.
Published: (2018-09-01) -
Simeprevir in combination with pegylated interferon-α and ribavirin in the treatment of naïve patients with genotype 1 chronic hepatitis C
by: É Z Burnevich
Published: (2014-11-01) -
Sofosbuvir and Simeprevir for the Treatment of Recurrent Hepatitis C with Fibrosing Cholestatic Hepatitis after Liver Transplantation
by: D Issa, et al.
Published: (2016-01-01) -
New treatments for genotype 1 chronic hepatitis C – focus on simeprevir
by: Kanda T, et al.
Published: (2014-05-01)